When does 180 LIFE SCIENCES CORP (ATNF) report earnings?
180 LIFE SCIENCES CORP (ATNF) will report earnings on 2025-11-12.
NASDAQ:ATNF • US68236V3024
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for 180 LIFE SCIENCES CORP (ATNF).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-05-09 | Maxim Group | Downgrade | Buy -> Hold |
| 2021-09-15 | Maxim Group | Initiate | Buy |
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 137.52% | N/A 89.26% | N/A 76.76% | N/A 54.84% | N/A 39.14% | ||||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | -5.523M | -15.531M -181.22% | -17.789M -14.54% | -13.372M 24.83% | -6.266M 53.14% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.1K | -343.9K -10,993.55% | -599.1K -74.21% | -1.209M -101.79% | -5.648M -367.21% | -15.641M -176.92% | -17.898M -14.43% | -13.478M 24.70% | -6.325M 53.07% | N/A -69.67% | N/A 160.07% | N/A 367.55% | N/A 132.39% | N/A 69.99% | N/A 45.53% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A 92.59% | N/A 73.68% | N/A 50.00% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
180 LIFE SCIENCES CORP (ATNF) will report earnings on 2025-11-12.
The consensus rating for 180 LIFE SCIENCES CORP (ATNF) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.